Biosyent Inc (RX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,989 | 4,381 | 2,316 | 1,058 | 471 |
| Marketable Securities | 1,000 | N/A | N/A | N/A | N/A |
| Receivables | 641 | 586 | 590 | 335 | 286 |
| Inventories | 1,272 | 523 | 346 | 121 | 58 |
| Other current assets | 143 | 0 | 0 | 0 | 0 |
| TOTAL | $10,248 | $5,626 | $3,323 | $1,550 | $899 |
| Non-Current Assets | |||||
| PPE Net | 157 | 141 | 98 | 30 | 25 |
| Intangibles | 67 | 53 | 0 | 4 | 4 |
| Other Non-Current Assets | 173 | 272 | 232 | 0 | 0 |
| TOTAL | $397 | $466 | $330 | $35 | $28 |
| Total Assets | $10,645 | $6,092 | $3,653 | $1,585 | $927 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,993 | 768 | 723 | N/A | N/A |
| TOTAL | $2,461 | $1,220 | $813 | $422 | $256 |
| Non-Current Liabilities | |||||
| TOTAL | $23 | $17 | $0 | $0 | $0 |
| Total Liabilities | $2,485 | $1,237 | $813 | $422 | $256 |
| Shareholders' Equity | |||||
| Common Shares | 7,138 | 7,080 | 7,018 | 0 | 6,873 |
| Retained earnings | 734 | -2,420 | -4,348 | -5,890 | -6,306 |
| Other shareholders' equity | 13 | 5 | -4 | -2 | 0 |
| TOTAL | $8,160 | $4,855 | $2,839 | $1,163 | $671 |
| Total Liabilities And Equity | $10,645 | $6,092 | $3,653 | $1,585 | $927 |